Related Experiment Video
Updated: Mar 23, 2026

Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes
Published on: January 3, 2020
Imperatorin inhibits the expression of alpha-hemolysin in Staphylococcus aureus strain BAA-1717 (USA300)
Ping Ouyang1, Junjie Chen1, Mao Sun1
1College of Veterinary Medicine, Sichuan Agriculture University, Chengdu, China.
Abstract:
Both community-associated and hospital-acquired infections with methicillin-resistant Staphylococcus aureus (MRSA) have been increasingly reported around the world in the past 20 years. In 2006, the Centers for Disease Control and Prevention reported that 64 % of MRSA isolates were of the USA300 clonal type in infected patients in USA. The aim of our study was to estimate the in vitro effect of imperatorin on MRSA strain BAA-1717 (USA300). The effects of imperatorin on alpha-hemolysin (Hla) production, when strain BAA-1717 was co-cultured with sub-inhibitory concentrations of imperatorin, were analysed using susceptibility testing, hemolysis assays, western blotting and real-time PCR. Live/Dead analysis and cytotoxicity assays were employed to examine the protective effect of imperatorin against the strain BAA-1717-mediated injury of human alveolar epithelial cells (A549). The results showed that imperatorin has no anti-S. aureus activity at the tested concentrations in vitro. However, imperatorin can observably inhibit the production of Hla in culture supernatants and reduce the transcriptional levels of hla (the gene encoding Hla) and arg (the accessory gene regulator). Imperatorin prevented Hla-mediated A549 epithelial cell injury in a co-culture system. In conclusion, our results suggested that imperatorin has the potential to be developed as a new anti-virulence drug candidate for managing S. aureus infection.
Insights
Imperatorin does not kill methicillin-resistant Staphylococcus aureus (MRSA) but reduces its virulence. This natural compound protects lung cells from MRSA-induced damage, showing potential as an anti-virulence drug.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) infections are a growing global health concern.
- The USA300 clonal type is a prevalent cause of MRSA infections.
Purpose of the Study:
- To investigate the in vitro effects of imperatorin on MRSA strain BAA-1717 (USA300).
- To assess imperatorin's impact on alpha-hemolysin (Hla) production and its protective effects on human alveolar epithelial cells.
Main Methods:
- Susceptibility testing, hemolysis assays, western blotting, and real-time PCR were used to analyze Hla production.
- Live/Dead analysis and cytotoxicity assays evaluated imperatorin's protective effects on A549 cells.
Main Results:
- Imperatorin demonstrated no direct anti-MRSA activity at tested concentrations.
- Imperatorin significantly inhibited Hla production and reduced the transcription of hla and arg genes.
- Imperatorin protected A549 cells from Hla-mediated injury.
Conclusions:
- Imperatorin exhibits anti-virulence properties against MRSA by targeting Hla.
- Imperatorin shows potential as a novel therapeutic candidate for managing Staphylococcus aureus infections.
More Related Videos
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Bacterial Protein Synthesis
Staphylococcal Skin Infections
Regulation of Bacterial Virulence
Gene Regulation in Microbial Communities: Quorum Sensing

